Milan, Italy

Emilio Crisafulli


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 1984-1990

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Emilio Crisafulli: Innovator in Pharmaceutical Advancements

Introduction

Emilio Crisafulli is a notable Italian inventor based in Milan, renowned for his contributions to the field of pharmaceuticals. With an impressive portfolio of seven patents, Crisafulli has made significant advancements in age-defying treatments and anticancer agents.

Latest Patents

Among his latest innovations, Crisafulli's patent for "Composition and use of ademetionine against ageing of the skin" stands out. This invention involves the use of ademetionine or its salts for formulating pharmaceutical or cosmetic compositions aimed at counteracting skin aging. Furthermore, his patent related to "Hydrochlorides of chlorides of 2-aminoalkyl-9-hydroxy-ellipticinium" focuses on novel compounds useful as antitumor agents, expanding the arsenal against cancer through innovative chemical compositions.

Career Highlights

Throughout his career, Crisafulli has collaborated with prestigious companies, notably Sanofi and Société Anonyme Sanofi. His work at these organizations has facilitated significant research and development initiatives, contributing to his growing reputation in the field of medical innovation.

Collaborations

Crisafulli has shared his journey with talented individuals such as Dino Nisato and Alberto Bianchetti. These collaborations have enhanced his work, fostering an environment of innovation and creativity that has led to successful patent applications and groundbreaking discoveries.

Conclusion

Emilio Crisafulli's dedication to advancing pharmaceutical technologies is evident in his innovative patents and collaborations. As he continues to break new ground in the field, his contributions remain vital to addressing critical health challenges, particularly in anti-aging and cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…